GlassScriptPhysician profile
Catherine Grace Pyle
NPI 1437843125
$1,484.78
in general payments reported to CMS, 2019-2025
11 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $111 · 2024: $262 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $582.24 | 2024-2025 | |
| Lifenet Health | $483.03 | 2024-2025 | Theragenesis Wound Matrix |
| Abbvie INC. | $208.96 | 2023-2025 | |
| Smith+Nephew, INC. | $45.86 | 2024-2025 | Stravix Pl, Collagenase Santyl |
| Mentor Worldwide LLC | $43.83 | 2025 | Artoura Breast Tissue Expander |
| Revance Therapeutics, INC. | $22.93 | 2025 | Daxxify |
| Integra Lifesciences Corporation | $21.87 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Organogenesis INC. | $21.86 | 2025 | Cygnus Dual |
| Ethicon US, LLC | $20.40 | 2025 | Stratafix, Surgicel Nu-Knit, Dermabond Prineo |
| Biocomposites INC | $18.78 | 2025 | Stimulan |
| Motiva USA, LLC | $15.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Pyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.